CME Credit Available:

This activity offers .50 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Understand the changing ecosystem of Testosterone Replacement Therapy (TRT) Develop a framework/approach to evaluating Testosterone (T) 
• Improve competence in management of low testosterone
• Apply skills and techniques to better serve your patients

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Andrew Hamilton, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Discuss clinical stratification for neurological cases. 
• Discuss a general overview of multiple sclerosis.
• Discuss a general overview of types of strokes.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Scott Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers 1.00 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Upon completion, participants will be able to describe and evaluate for common causes of telogen effluvium. 
• Upon completion, participants will be able to describe the cutaneous manifestations of rheumatologic disease, namely dermatomyositis and lupus as well as identify the systemic comorbidities of psoriasis.
• Upon completion, participants will be able to identify common cutaneous manifestations of gastrointestinal, renal, endocrine, and hematologic diseases.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Molly Menser, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .50 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Educate patients on appropriate diets tailored to their comorbid conditions. 
• Prevent exacerbations of selected conditions by prescribing appropriate diets.
• Improve patients’ health outcomes by choosing selected diets.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert Hasty, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Diagnosis and management of myopathies and treatments.
• Diagnosis and management of Parkinson's, seizures, and motor disorders.
• Diagnosis and management of headaches and treatments.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Scott Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .50 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Diagnose selected genetic conditions. 
• Anticipate selected conditions based upon patients’ genetics disorders.
• Correlate genetic inheritance with selected conditions.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert Hasty, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .50 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• How to work up and diagnose a polyneuropathy. 
• How to work up an acute neuropathy.
• How to recognize and diagnose a mononeuropathy multiplex.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Scott Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .50 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• The learner should be familiar with the basic indications and approaches to arthrocentesis (non-ultrasound guided techniques) 
• The learner should know the four basic categories of classification of synovial fluids
• Understand how synovial fluid analysis including compensated polarized light microscopy can aid in the diagnosis and correct treatment in patients with joint diseases

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert DiGiovanni, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .50 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• HIV arthritis affects 12–63% of HIV patients on ART, highlighting its significant clinical burden. 
• Understand rheumatic fever as an immunologically mediated late complication of Group A streptococcal (GAS) pharyngeal infection.
• Prevention is key for Lyme disease. Proper tick removal within 36–48 hours, avoidance of folk remedies, and awareness of the VLA15 vaccine pipeline are all essential components of patient education.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Rubaiya Mallay, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .50 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Recall the clinical features and presentations of vasculitis in a case-based format. 
• Interpretation of the unique labs used to help diagnose vasculitis.
• Become familiar with current treatment strategies for this group of disorders.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert DiGiovanni, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.